1. Current Controversies in the Treatment of HIV Infection and AIDS

   • Stavros Petrou

   Current Opinion 25 November 2012 Pages: 105 - 108

2. Combination Antiretroviral Therapy in HIV Infection

   • Richard D. Moore
   • John G. Bartlett

   Current Opinion 25 November 2012 Pages: 109 - 113

3. Economic Evaluation in Healthcare

   • Karen Blumenschein
   • Magnus Johannesson

   Leading Article 25 November 2012 Pages: 114 - 122

4. The Expanding Role of Pharmacy and Therapeutics Committees

   • William E. Wade
   • William J. Spruill
   • David W. Hawkins

   Leading Article 25 November 2012 Pages: 123 - 128

5. Cost-Effective Prophylaxis of Surgical Infections

   • S. Ragnar Norrby

   Review Article 25 November 2012 Pages: 129 - 140

6. The Cost Effectiveness of Diclofenac Plus Misoprostol Compared with Diclofenac Monotherapy in Patients with Rheumatoid Arthritis

   • Maiwenn J. Al
   • Bowine C. Michel
   • Frans F. H. Rutten

   Original Research Article 25 November 2012 Pages: 141 - 151

7. Hypnotics

   • Robert Janknegt
   • Ary van der Kuy
   • Chris Idzikowski

   Original Research Article 25 November 2012 Pages: 152 - 163

8. Cefpodoxime Proxetil

   • Julia A. Balfour
   • Paul Benfield

   Pharmacoeconomic Drug Evaluation 25 November 2012 Pages: 164 - 178

9. Enoxaparin

   • Christopher J. Dunn
   • Karen L. Goa

   Pharmacoeconomic Drug Evaluation 25 November 2012 Pages: 179 - 190

10. Orphan Drug Policy

    • Todd Rich

    Correspondence 25 November 2012 Pages: 191 - 191

11. Orphan Drug Policy

    • John Peabody
    • Peter Cannon

    Correspondence 25 November 2012 Pages: 191 - 192

12. Glossary

    News 25 November 2012 Pages: 193 - 196